Moderna
MRNA
#221
Rank
A$149.21 B
Marketcap
A$368.78
Share price
5.27%
Change (1 day)
867.84%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: A$149.21 Billion

As of November 2026 Moderna has a market cap of A$149.21 Billion. This makes Moderna the world's 221th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026A$149.21 B719.83%
2025A$18.20 B-26.69%
2024A$24.82 B-55.39%
2023A$55.65 B-45.11%
2022A$101.40 B-28.61%
2021A$142.03 B164.2%
2020A$53.76 B471.83%
2019A$9.40 B31.92%
2018A$7.12 B

End of Day market cap according to different sources

On Nov 8th, 2026 the market cap of Moderna was reported to be:

A$147.22 Billion
by Nasdaq info icon info icon
A$147.22 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$964.70 B 546.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$445.38 B 198.49%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
A$524.79 B 251.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
A$0.81 B-99.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
A$4.32 B-97.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
A$1.2 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$30.30 B-79.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
A$11.91 B-92.01%๐Ÿ‡บ๐Ÿ‡ธ USA